These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10688731)

  • 1. Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent.
    Kono T; Ishii M; Negoro N; Taniguchi S
    J Am Acad Dermatol; 2000 Mar; 42(3):519-20. PubMed ID: 10688731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uracil-tegafur in gastric carcinoma: a comprehensive review.
    Takiuchi H; Ajani JA
    J Clin Oncol; 1998 Aug; 16(8):2877-85. PubMed ID: 9704742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT).
    Yoshimasu T; Hiroi A; Uede K; Furukawa F
    Eur J Dermatol; 2001; 11(1):54-7. PubMed ID: 11174141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UFT-induced haemolytic anaemia.
    Zurita Saavedra AJ; Navarro Garcia M; Español I; Fernández Ortega A
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):280-1. PubMed ID: 11320674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
    Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
    J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the intensity of MMC and UFT in postoperative adjuvant chemotherapy for gastric cancer--study report of JFMTC Study No. 10].
    Danno M; Shiroto H; Kunii Y; Ishibiki K; Yamamura Y; Sakamoto Y; Tamura Y; Kunitomo K; Kumashiro R;
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):195-203. PubMed ID: 11242646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
    Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
    Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
    Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's phenomenon possibly induced by a compund drug of tegafur and uracil.
    Seishima M; Izumi T; Kanoh H
    Eur J Dermatol; 2000; 10(1):55-8. PubMed ID: 10694301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of pulmonary metastasis from renal cell carcinoma with complete response to interferon-alpha and tegafur/uracil (UFT) but possibly UFT-induced liver dysfunction and leukoencephalopathy-like symptoms].
    Suzuki K; Nukui A; Kobayashi M; Sugaya Y; Muraishi O; Morita T; Tokue A
    Hinyokika Kiyo; 1999 Sep; 45(9):621-4. PubMed ID: 10540708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of tegafur-uracil (UFT) administration in castration-resistant prostate cancer patients with a history of both alternative antiandrogen therapy and estramustine phosphate sodium hydrate therapy.
    Hayakawa N; Matsumoto K; Sato A; Sakamoto H; Ezaki T; Maeda T; Ninomiya A; Nakamura S
    Int Urol Nephrol; 2014 Jun; 46(6):1123-9. PubMed ID: 24356920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
    Matsuda C; Ishiguro M; Teramukai S; Kajiwara Y; Fujii S; Kinugasa Y; Nakamoto Y; Kotake M; Sakamoto Y; Kurachi K; Maeda A; Komori K; Tomita N; Shimada Y; Takahashi K; Kotake K; Watanabe M; Mochizuki H; Nakagawa Y; Sugihara K;
    Eur J Cancer; 2018 Jun; 96():54-63. PubMed ID: 29677641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
    Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
    Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group.
    Feliu J; González Barón M; Espinosa E; García Girón C; de la Gándara I; Espinosa J; Colmenarejo A; Jalón JI; Fernández Y; de Castro J
    Cancer; 1997 May; 79(10):1884-9. PubMed ID: 9149013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety and compliance with UFT (tegafur and uracil) alone and in combination with hormone therapy in patients with breast cancer].
    Taguchi T; Noguchi S
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1465-74. PubMed ID: 19755814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase inhibition by an oral regimen consisting of tegafur-uracil (UFT) and low-dose leucovorin for patients with gastric cancer.
    Ichikura T; Tomimatsu S; Okusa Y; Yahara T; Uefuji K; Tamakuma S
    Cancer Chemother Pharmacol; 1996; 38(5):401-5. PubMed ID: 8765432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multihospital randomized study on adjuvant chemotherapy with mitomycin C and futraful or UFT in gastric cancer (Part 1). Comparison between futraful and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy)].
    Arima S; Simura H; Yamanouchi A; Fukuyama N; Hisatsugu T; Yamamoto H; Ohsato K; Ohkuma R; Nakamura Y; Abe R
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2524-31. PubMed ID: 3113340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
    Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian variations in the pharmacokinetics of the oral anticancer agent tegafur-uracil (UFT) and its metabolites in rats.
    Kobuchi S; Ito Y; Takamatsu D; Sakaeda T
    Eur J Pharm Sci; 2018 Oct; 123():452-458. PubMed ID: 30077713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An elderly patient with advanced gastric cancer maintaining complete response for over 3 years by oral administration of UFT following short span of S-1].
    Yamanaka T; Okabe K; Sugiyama S; Sano O; Wada A; Beppu T; Baba H
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2424-6. PubMed ID: 21224594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.